Last €3.41 EUR
Change Today +0.005 / 0.15%
Volume 0.0
O5O On Other Exchanges
Symbol
Exchange
Helsinki
Helsinki
Berlin
OTC US
As of 2:06 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

oriola-kd oyj b shares (O5O) Snapshot

Open
€3.41
Previous Close
€3.41
Day High
€3.41
Day Low
€3.41
52 Week High
12/22/14 - €3.42
52 Week Low
09/17/14 - €2.13
Market Cap
523.8M
Average Volume 10 Days
130.0
EPS TTM
--
Shares Outstanding
104.1M
EX-Date
03/25/14
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORIOLA-KD OYJ   B SHARES (O5O)

Related News

No related news articles were found.

oriola-kd oyj b shares (O5O) Related Businessweek News

No Related Businessweek News Found

oriola-kd oyj b shares (O5O) Details

Oriola-KD Corporation operates as a pharmaceutical retail and wholesale company in Northern Europe and Russia. The company operates in Pharmaceutical Trade Finland and Baltics, Pharmaceutical Trade Sweden, and Pharmaceutical Trade Russia segments. It distributes various pharmaceuticals; and provides various added value services for pharmaceutical manufacturers and pharmacies, such as distribution of clinical trials medicines and medical samples, as well as storage and distribution services for marketing materials, and other logistics solutions. The company also sells and markets consumer health products that comprise vitamins, food supplements, pharmacy cosmetics, skincare products, tests, sports drinks, and wound care products to pharmacies and the groceries. It has 290 pharmacies in Sweden; and 239 pharmacies located in Moscow. The company is headquartered in Espoo, Finland.

4,738 Employees
Last Reported Date: 10/23/14

oriola-kd oyj b shares (O5O) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: €569.7K
Compensation as of Fiscal Year 2013.

oriola-kd oyj b shares (O5O) Key Developments

Oriola-KD Corporation Revises Earnings Guidance for the Year 2014

Oriola-KD Corporation revised earnings guidance for the year 2014. For the year, the company estimated that net sales from continuing operations will be at the level of 2013 and operating profit excluding non-recurring items from continuing operations will increase from 2013 level.

Oriola-KD Corporation - Special Call

To discuss on the sale of Russian businesses

Oriola-KD Corporation Announces resignation of Konstantin Minin as member of its management team, Effective December 8, 2014

Oriola-KD Corporation announced that Konstantin Minin, Vice President, Pharmaceutical Retail and Wholesale, Russia will leave his position as a member of the Oriola-KD group management team December 8, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
O5O:GR €3.41 EUR +0.005

O5O Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for O5O.
View Industry Companies
 

Industry Analysis

O5O

Industry Average

Valuation O5O Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORIOLA-KD OYJ B SHARES, please visit www.oriola-kd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.